This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
saas: Archive
Eldorado Gold Corporation (EGO) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
EGONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
4 Software Stocks Likely to Beat Earnings Estimates This Season
by Anirudha Bhagat
Let us examine some software stocks, such as AFRM, XYZ, BILL and TEAM, which are poised to beat earnings estimates this season.
TEAMPositive Net Change BILLPositive Net Change AFRMPositive Net Change XYZNegative Net Change
artificial-intelligence cloud-computing computers earnings saas tech-stocks
StoneCo Ltd. (STNE)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
STNEPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Top Cloud Computing Stocks to Bet on for Healthy Returns
by Supriyo Bose
MSFT, GOOGL, AMZN and IBM are indispensable cloud stocks for any investment portfolio.
AMZNPositive Net Change MSFTPositive Net Change IBMNegative Net Change GOOGLPositive Net Change
artificial-intelligence cloud-computing communications saas tech-stocks telecom
Should You Buy Regulus (RGLS) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Will NATO Deal Boost Palantir Stock? Consider PLTR Valuation First
by Tirthankar Chakraborty
Palantir's new military deal has boosted its future growth prospects. Is it the ideal time to invest, or should we wait for a better opportunity?
ADPPositive Net Change ANETNegative Net Change PLTRPositive Net Change
saas tech-stocks
Can Strong Recurring Revenue Growth Push SPNS Stock Higher in 2025?
by Zacks Equity Research
Sapiens leverages cloud, recurring revenues, and partnerships to strengthen its position in the insurtech domain.
MSFTPositive Net Change CTSHPositive Net Change
insurance saas
Newmont Corporation (NEM) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
NEMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Nutanix Dips 12% in a Month: Should You Hold or Fold the Stock?
by Zacks Equity Research
NTNX shows promising long-term prospects, but elongated sales cycles and margin pressures suggest investors should hold the stock for now.
CSCONegative Net Change DELLNegative Net Change HPENegative Net Change NTNXNegative Net Change
saas tech-stocks
How Should You Play Stratasys Stock After $120M Fortissimo Deal?
by Zacks Equity Research
Stratasys secures $120 million investment while facing headwinds. You can hold SSYS stock or wait for better entry points as recovery develops gradually through 2025.
LOGINegative Net Change SSYSNegative Net Change IMMRNegative Net Change APELYPositive Net Change
industrial-products saas